Bobak R. Azamian - Mar 17, 2023 Form 4 Insider Report for Tarsus Pharmaceuticals, Inc. (TARS)

Role: President/CEO and Board Chair, Director
Signature: /s/ Leonard M. Greenstein, Attorney-in-Fact
Stock symbol: TARS
Transactions as of: Mar 17, 2023
Transactions value $: -$19,902
Form type: 4
Date filed: 3/21/2023, 07:01 PM
Previous filing: Mar 17, 2023
Next filing: Mar 23, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TARS	Common Stock	Sale	-$10.6K	-795	-6.49%	$13.28	11.5K	Mar 17, 2023	Direct	F1
transaction	TARS	Common Stock	Sale	-$9.34K	-741	-6.46%	$12.61	10.7K	Mar 20, 2023	Direct	F1
holding	TARS	Common Stock						1.08M	Mar 17, 2023	By the Bobak Azamian Living Trust, established April 16, 2018	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
F2	The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares.

Content

The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.

The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares.